Skip to content
Recall Observatory FDA recall evidence

Drug product

Irbesartan Tablets USP, 150 mg a) 30 count (NDC 68180-411-06) and b) 90 count (NDC 68180-411-09) bottles, Rx only

D-0087-2022

October 12, 2021

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 88856
Status
Terminated
Classification
Class II
Quantity
134,016 bottles
Official record key
drug-enforcement:D-0087-2022

Official wording

Reason: CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Code information: a) Lot# H804403, exp. date 31/08/2021 H805251, exp. date 30/11/2021 H805640, exp. date 30/11/2021 H901580; exp. date 30/04/2022 b) Lot# H804492, exp. date 31/08/2021 H805252, exp. date 30/11/2021 H805253, exp. date30/11/2021 H805641, exp. date30/11/2021 H805642, exp. date30/11/2021 H805643, exp. date 30/11/2021 H901581, exp. date 30/04/2021 H902139, exp. date 30/04/2022 H902140, exp. date 30/04/2022

Distribution pattern: Product was distributed to major distributors who may have further distributed the product nationwide.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    impurity N-nitrosoirbesartan detected in API
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations